QUASAR’s dry electrode technology offers benefits to any application that requires long term, at home, or ambulatory monitoring. Our systems provide quick application and support patient compliance. Some of our potential applications are:
• Neonatal monitoring
• Seizure monitoring
• TBI assessment
• PTSD assessment
• Neurological disorder diagnosis
• Neurofeedback
• Intensive care monitoring
• Arrythmia monitoring
Neonatal monitoring
Neonates’ delicate skin can be damaged by standard electrode technology. Working with Children’s National Medical Center under NIH funding, QUASAR is developing a gentle, dry electrode EEG system designed specifically to meet the needs of neonates and the medical professionals caring for them. The miniaturized dry electrodes developed under this effort have broad utility for pediatric applications.
Stroke rehabilitation
QUASAR technology powers Neurolutions’ IpsiHand stroke rehab system. Electrodes sense a movement-impaired patient’s intention to move their hand from a healthy part of their brain and the signal is transmitted to a splint-like device that moves the hand for the patient. It’s thought that this retrains the brain for hand movement as study participants experienced clinically significant improvement in their mobility. QUASAR is proud to have our technology helping stroke patients recover.
fNIR
Functional near-infrared spectroscopy (fNIR) is a non-invasive, light-based neuroimaging technique that measures brain activity by detecting changes in blood oxygenation levels. Although currently mostly a research modality, fNIR is attractive to medical professionals due to its non-invasive nature, portability, and accessibility. QUASAR is excited about the potential of fNIR, particularly when paired with EEG in integrated devices.
Dry Electrocardiogram
QUASAR has produced precision dry electrocardiogram (ECG) electrodes that can acquire the ECG waveform on subjects who are moving, sweating, wet or even underwater. Long term monitoring applications include arrythmia detection and drug development.